Senseonics Holdings, Inc.
NASDAQ:SENSMedical - Devices
-$0.09 today
- Market cap
- $533.56M
- Beta
- 0.97
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$1.90
Volume 0.87M
Average 0.71M
SENS Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Senseonics Holdings, Inc.NASDAQ: SENS
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $545K rose 41.9% year over year, ahead of the -1.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 42.7% from the prior quarter. Over 3 fiscal years it compounded at +15.4% a year.
Context
- Depreciation & amortization amounted to 4.3% of revenue in FY2025, down 2.3 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +41.9% holds above the trailing-twelve-month pace of -1.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 1.51M USD
- Year-over-year change
- +2.5%
- 4-year CAGR
- +5.1%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.51M | +2.5% |
| FY2024 | 2024-12-31 | 1.48M | +15.5% |
| FY2023 | 2023-12-31 | 1.28M | +29.6% |
| FY2022 | 2022-12-31 | 985K | -20.5% |
| FY2021 | 2021-12-31 | 1.24M | — |
Depreciation & Amortization vs competitors
How SENS compares with its peers on the latest reported figures
- SENS's LTM Mar 2026 depreciation & amortization of $1.67M is the lowest of the 6 companies compared; the peer median is $99.3M.
- Its year-over-year change of -1.0% is the lowest of 5, against a peer median of +13.1%.
- Depreciation & amortization amounts to 4.1% of revenue for SENS, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $264.1M | +11.9% | +17.3% | 5.3% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | $158M | — | +10.7% | 4.9% |
| LTM Jun 2026 | $99.3M | +14.4% | +12.7% | 3.3% | |
| LTM Mar 2026 | $17.86M | +5.8% | +7.2% | 1.7% | |
| LTM Mar 2026 | $2.94M | +46.0% | +28.8% | 2.7% | |
| LTM Mar 2026 | $1.67M | -1.0% | +15.4% | 4.1% | |
| Peer median (excluding SENS) | $99.3M | +13.1% | +12.7% | 3.3% | |
Competitors are the stored peer set for SENS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.68M | 16.39M | 22.39M | 22.47M | 35.26M |
| Cost of Revenue | 14.49M | 13.66M | 19.3M | 21.94M | 19.49M |
| Gross Profit | (811K) | 2.73M | 3.09M | 533K | 15.76M |
| Gross Margin | -5.9% | 16.6% | 13.8% | 2.4% | 44.7% |
| Research & Development | 27.22M | 39.72M | 48.75M | 41.14M | 31.59M |
| Selling, General & Admin | 29.15M | 31.63M | 29.94M | 34.23M | 52.51M |
| Operating Expenses | 56.37M | 71.35M | 78.69M | 75.38M | 84.1M |
| Depreciation & Amortization | 1.24M | 985K | 1.28M | 1.48M | 1.51M |
| EBITDA | (284.52M) | 161.81M | (48.01M) | (68.7M) | (62.65M) |
| EBITDA Margin | -2080.5% | 987.3% | -214.4% | -305.7% | -177.7% |
| Operating Income | (57.18M) | (68.63M) | (75.6M) | (74.84M) | (68.34M) |
| Operating Margin | -418.1% | -418.7% | -337.7% | -333.0% | -193.8% |
| Interest Income | 243K | 1.82M | 5.36M | 4.5M | 4.2M |
| Interest Expense | 16.72M | 18.7M | 11.11M | 8.44M | 4.95M |
| Other Income / Expenses | (245.29M) | 210.75M | 15.21M | (3.77M) | (776K) |
| Income Before Tax | (302.47M) | 142.12M | (60.39M) | (78.62M) | (69.11M) |
| Pre-Tax Margin | -2211.9% | 867.2% | -269.7% | -349.8% | -196.0% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (302.47M) | 142.12M | (60.39M) | (78.62M) | (69.11M) |
| Net Margin | -2211.9% | 867.2% | -269.7% | -349.8% | -196.0% |
| EPS (Basic) | (14.40) | 6.07 | (2.20) | (2.50) | (1.66) |
| EPS (Diluted) | (14.40) | (2.17) | (2.20) | (2.50) | (1.66) |
| Weighted Avg Shares | 21.12M | 23.4M | 28.4M | 31.49M | 41.73M |
| Weighted Avg Shares (Diluted) | 21.12M | 30.91M | 28.4M | 31.49M | 41.73M |
Senseonics Holdings, Inc.
NASDAQ:SENS
Intrinsic Alpha fair value
Locked
Current Price
$9.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.